Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial. (2023)

First Author: Bevers LAH
Attributed to:  Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciad346

PubMed Identifier: 37280040

Publication URI: http://europepmc.org/abstract/MED/37280040

Type: Journal Article/Review

Volume: 77

Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Issue: 9

ISSN: 1058-4838